In today’s issue: Shining the spotlight on BioNTech’s Africa plans; Moderna expands more; Molnupiravir not likely in the EU; Aduhelm’s woes continue; The “long Covid” crisis; Covid and the immunocompromised; A return to normal in Australia
💊 mRNA money spreads wings around the world; Biogen worries multiply; What about long Covid?
